Cambrian
Erik Schneider is a Director of Business Development at Cambrian Biopharma. Previously, Erik was on the Business Development and Licensing team at Novartis, evaluating deal and portfolio strategy across cardiovascular, immunology, and neuroscience franchises. Prior to joining Novartis, Erik was a consultant at CBPartners (now Trinity Life Sciences), with a focus on commercial and pricing strategy for new products. Erik graduated from the College of the Holy Cross with a degree in Biochemistry.
This person is not in any teams
Cambrian
Cambrian is developing a raft of new companies and therapies to extend healthy lifespan, bringing proven scientific and organizational expertise to exceptional research teams worldwide.